- Red Light Holland (TRIP has received a report from the first stability test conducted on the company’s Psilocybin Truffles
- The reportconfirmed that the company’s iMicrodose packs retain their psilocybin equivalent content of 1.23 mg/gram one week after opening
- Red Light Holland’s partner, CCrest Laboratories will continue to work towards creating a standardized consistent dose
- Red Light Holland is engaged in the production, growth and sale of a premium brand of magic truffles
- Red Light Holland Corp. (TRIP) is down 5.26 on the day, trading at C$0.09 per share at 1:45 pm ET
Red Light Holland (TRIP) has received a report from the first stability test conducted on the company’s Psilocybin Truffles.
The report was focused on optimizing shelf life and the long-term quality of the product.
The report confirmed Red Light Holland’s iMicrodose packs containing tampanensis truffles have a psilocybin equivalent content of 1.23 mg/gram one week after opening the truffles. This baseline measurement will help in future studies to research Psilocybin content over longer periods of time which will be crucial in any potential clinical use of naturally occurring Psilocybin. The report also confirmed the importance of keeping fresh truffles refrigerated after opening them, which Red Light Holland currently mentions on all iMicrodose packs sold.
The testing performed by CCrest Laboratories in Montreal demonstrates the company’s commitment to standardization, research and development to advocate to Health Canada that their farm-grown truffles could be an option of naturally occurring psychedelics for those patients in need under the new Special Access Program (“SAP”).
CCrest Laboratories, Red Light Holland’s partner, has been listed as a provider of Psilocybin via SAP, if and when requests are made by health practitioners and all Government approvals are met.
“Step by step we continue to move towards a standardized consistent dose of naturally occurring psilocybin truffles that can potentially benefit all legal markets,” said Todd Shapiro, CEO and Director of Red Light Holland.
“As far as we know our truffles are the first to go through such rigorous testing which shows our commitment to increasing scientific knowledge of these natural products and having the best products on the market. The legal market in the Netherlands and the market opening in Oregon next year are focused on naturally occurring Psilocybin which our market research shows many people prefer over synthetics – so it’s exciting that Red Light Holland with the help of Shaman Pharma is working towards giving people what they want. We hope other governments around the world will follow to legalize the responsible use of a substance that has been used by many civilizations for thousands of years.”
“Working with natural Psilocybin is exciting and we continue to learn and progress our methods of discovery,” said Alex Grenier, CEO of Shaman Pharma and President of CCrest Laboratories.
Red Light Holland’s partner, CCrest Laboratories, will continue to perform stability tests and R&D towards creating a standardized consistent dose from naturally occurring psilocybin truffles.
Red Light Holland continues to establish itself as a leader in the recreational sector, pushing for legal, responsible, and safe access to natural psychedelic truffles/mushrooms.
Red Light Holland is engaged in the production, growth and sale of a premium brand of magic truffles.
Red Light Holland Corp. (TRIP) is down 5.26 on the day, trading at C$0.09 per share at 1:45 pm ET.
